Literature DB >> 24292974

Functional consequences of chronic bladder ischemia.

Osamu Yamaguchi1, Masanori Nomiya, Karl-Erik Andersson.   

Abstract

The pathophysiology of lower urinary tract symptoms (LUTS), particularly in the elderly, seems to be multifactorial. One of the factors involved may be chronic ischemia of the bladder caused by bladder outflow obstruction (male) or atherosclerosis (male/female). The mechanisms by which chronic ischemia initiates and causes LUTS and progressive bladder dysfunction, and the time course of the effects, are incompletely known. Bladder ischemia and repeated ischemia/reperfusion during a micturition cycle may produce oxidative stress, leading to denervation of the bladder and the expression of tissue damaging molecules in the bladder wall. This may be responsible for the development of detrusor overactivity progressing to detrusor underactivity and inability to empty the bladder. The extent of bladder dysfunction in chronic bladder ischemia may depend on the degree and duration of ischemia. To prevent chronic bladder ischemia caused by atherosclerosis and to treat its consequences, more pathophysiological knowledge is needed. Several animal models of atherosclerosis-induced chronic bladder ischemia are available and should be useful tools for further research.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  aging; atherosclerosis; bladder dysfunction; bladder ischemia; detrusor overactivity; detrusor underactivity; lower urinary tract symptoms; oxidative stress

Mesh:

Year:  2013        PMID: 24292974     DOI: 10.1002/nau.22517

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  27 in total

1.  Association between Sarcopenia and Overactive Bladder in Elderly Diabetic Patients.

Authors:  S Ida; R Kaneko; H Nagata; Y Noguchi; Y Araki; M Nakai; S Ito; K Imataka; K Murata
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

Review 2.  The link between vascular dysfunction, bladder ischemia, and aging bladder dysfunction.

Authors:  Karl-Erik Andersson; Donna B Boedtkjer; Axel Forman
Journal:  Ther Adv Urol       Date:  2016-11-04

Review 3.  Inflammasomes in the urinary tract: a disease-based review.

Authors:  J Todd Purves; F Monty Hughes
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-11

Review 4.  The Emerging Role of Inflammasomes as Central Mediators in Inflammatory Bladder Pathology.

Authors:  Brian M Inouye; Francis M Hughes; Stephanie J Sexton; J Todd Purves
Journal:  Curr Urol       Date:  2017-12-30

5.  Association between coronary artery disease severity and overactive bladder in geriatric patients.

Authors:  Muhammet Fatih Kilinc; Erdogan Yasar; Halil Ibrahim Aydin; Yildiray Yildiz; Omer Gokhan Doluoglu
Journal:  World J Urol       Date:  2017-10-14       Impact factor: 4.226

6.  Cardiovascular risk independently predicts small functional bladder storage capacity.

Authors:  Thomas F Monaghan; Connelly D Miller; Christina W Agudelo; Syed N Rahman; Karel Everaert; Lori A Birder; Alan J Wein; Jeffrey P Weiss; Jason M Lazar
Journal:  Int Urol Nephrol       Date:  2020-08-17       Impact factor: 2.370

7.  The NLRP3 Inflammasome Mediates Inflammation Produced by Bladder Outlet Obstruction.

Authors:  Francis M Hughes; Hayden M Hill; Case M Wood; Andrew T Edmondson; Aliya Dumas; Wen-Chi Foo; James M Oelsen; Goran Rac; J Todd Purves
Journal:  J Urol       Date:  2015-12-18       Impact factor: 7.450

Review 8.  Pharmacological treatment of chronic pelvic ischemia.

Authors:  Karl-Erik Andersson; Masanori Nomiya; Norifumi Sawada; Osamu Yamaguchi
Journal:  Ther Adv Urol       Date:  2014-06

Review 9.  OnabotulinumtoxinA Treatment for Overactive Bladder in the Elderly: Practical Points and Future Prospects.

Authors:  Hann-Chorng Kuo
Journal:  Drugs Aging       Date:  2016-01       Impact factor: 3.923

10.  New Diagnostics for Male Lower Urinary Tract Symptoms.

Authors:  Natalie R Swavely; John E Speich; Lynn Stothers; Adam P Klausner
Journal:  Curr Bladder Dysfunct Rep       Date:  2019-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.